Pirinase Allergy 0.05% w/w Nasal Spray (fluticasone propionate)

Pirinase Allergy 0.05% w/w Nasal Spray (fluticasone propionate). Uses: Prevention and treatment of allergic rhinitis. Dosage and method of use: Adults, elderly and adolescents aged 12 years and over: Two sprays into each nostril once a day, preferably morning. Twice a day may be required in some cases. Maintenance: one spray per nostril once a day if possible. Use lowest possible maintenance dose. Max 4 sprays a day in each nostril. Children under 12 years: Not to be used. Contraindications: Hypersensitivity to ingredients. Concomitant use with HIV medicines. Precautions: Stop treatment or seek medical advice if improvement is not seen within 7 days. Seek medical advice if relief is inadequate, or if more than 3 months continuous use is required. Abnormally heavy challenge of summer allergens may in certain instances necessitate appropriate additional therapy. Seek medical advice before use with: other corticosteroid products, fever, nasal/sinus infection (treat appropriately), recent nasal injury/surgery, nasal ulceration. Caution due to interactions with cytochrome P450 3A4 inhibitors may increase systemic exposure to fluticasone. Caution commencing in those withdrawing from systemic steroids, and commencing therapy with intranasal fluticasone propionate, particularly if impairment of adrenal function suspected. Treatment with higher than recommended doses of nasal corticosteroids may result in clinically significant adrenal suppression. If there is evidence of higher than recommended doses being used, then additional systemic corticosteroid cover should be considered during periods of stress or elective surgery. Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These may include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children). May cause visual disturbance. Blurred vision or other visual disturbances should be considered for referral to an ophthalmologist for evaluation. Contains benzalkonium chloride which may cause bronchospasm. Side effects: Very Common: epistaxis. Common: Dryness and irritation of the nose and throat, unpleasant taste and smell, headache. See SPC for full details. Legal category: P. PL number: PL 44673/0099. Product licence holder: Haleon UK Trading Limited, The Heights, Weybridge, Surrey, KT13 0NY, UK. Package quantity and MRSP (excl. VAT): 60 sprays £8.32; 120 sprays £12.37. Date of last revision: Feb 2026.